Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
February 28, 2024 at 07:47 am
Share
Asian Phytoceuticals Public Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was THB 292.76 million compared to THB 250.38 million a year ago. Net income was THB 107.49 million compared to THB 80.92 million a year ago.
Basic earnings per share from continuing operations was THB 0.1792 compared to THB 0.1349 a year ago.
Asian Phytoceuticals Public Company Limited is a Thailand-based company, which is engaged in business of research and development, manufacturing, and distribution of its products for health and natural beauty. It operates through the manufacturing and distribution of dietary supplements from herbs. The Companyâs products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Companyâs slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
ASIAN PHYTOCEUTICALS 